OncoCyte Corp Business Finance Contracts & Agreements
35 Contracts & Agreements
- Equity Distribution Agreements (1 contract)
- Loan Agreements (3)
- Note Agreements (1)
- Purchase Agreements (8)
- Stock Agreements (3)
- Subscription Agreements (4)
- Underwriting Agreements (1)
- Warrant Agreements (14)
- Form of Securities Purchase Agreement (Filed With SEC on April 6, 2023)
- Second Amendment to Stock Purchase Agreement, dated February 16, 2023, by and among Dragon Scientific, LLC, Oncocyte Corporation and Razor Genomics Inc (Filed With SEC on February 23, 2023)
- First Amendment to Stock Purchase Agreement, dated December 15, 2022, by and among Dragon Scientific, LLC, Oncocyte Corporation and Razor Genomics Inc (Filed With SEC on February 3, 2023)
- Stock Purchase Agreement, dated December 15, 2022, by and among Dragon Scientific, LLC, Oncocyte Corporation and Razor Genomics Inc (Filed With SEC on December 21, 2022)
- Form of Warrant (Filed With SEC on April 19, 2022)
- Underwriting Agreement, dated April 13, 2022, between Oncocyte Corporation and BTIG, LLC, as representative of the underwriters named therein (Filed With SEC on April 19, 2022)
- Form of Securities Purchase Agreement, among us and certain investors, dated April 13, 2022 (Filed With SEC on April 13, 2022)
- Purchase Agreement, dated February 4, 2021, between OncoCyte Corporation and Piper Sandler & Co., as representative of the underwriters named therein (Filed With SEC on February 5, 2021)
- Subscription Agreements, dated January 20, 2021, between OncoCyte Corporation and the investors named therein (Filed With SEC on January 21, 2021)
- Loan Deferral Agreement, dated April 2, 2020, between OncoCyte Corporation and Silicon Valley Bank (Filed With SEC on May 12, 2020)
- U.S. Small Business Administration Paycheck Protection Program Note (Filed With SEC on April 29, 2020)
- Form of Subscription Agreements, dated April 24, 2020, between OncoCyte Corporation and the investors named therein (Filed With SEC on April 28, 2020)
- Equity Distribution Agreement, dated March 20, 2020 (Filed With SEC on March 20, 2020)
- Subscription Agreement, dated January 2, 2020, between Oncocyte Corporation and the investors named therein (Filed With SEC on January 6, 2020)
- Form of Subscription Agreement between OncoCyte Corporation and the investors party thereto (Filed With SEC on November 14, 2019)
- Warrant to Purchase Common Stock, dated October 17, 2019, between OncoCyte Corporation and Silicon Valley Bank (Filed With SEC on October 21, 2019)
- First Amendment to Loan and Security Agreement, dated October 17, 2019, between OncoCyte Corporation and Silicon Valley Bank (Filed With SEC on October 21, 2019)
- Warrant to Purchase Shares of Common Stock, dated August 1, 2019 (Filed With SEC on August 14, 2019)
- Purchase Agreement between OncoCyte Corporation and Piper Jaffray & Co. dated February 8, 2019 (Filed With SEC on February 12, 2019)
- Form of Securities Purchase Agreement, dated July 26, 2018, by and among OncoCyte Corporation and the investors signatory thereto (Filed With SEC on August 1, 2018)
- Form of Warrant (Filed With SEC on August 1, 2018)
- Form of Securities Purchase Agreement (Filed With SEC on March 29, 2018)
- WARRANT (Filed With SEC on July 26, 2017)
- WARRANT (Filed With SEC on July 26, 2017)
- WARRANT (Filed With SEC on July 26, 2017)
- WARRANT (Filed With SEC on July 26, 2017)
- Loan and Security Agreement, dated February 21, 2017, between OncoCyte Corporation and Silicon Valley Bank (Filed With SEC on February 27, 2017)
- Silicon Valley Bank Warrant (Filed With SEC on February 27, 2017)
- Form of 2017 Warrant, Exercise Price $5.50 (Filed With SEC on February 27, 2017)
- Form of 2017 Warrant, Exercise Price $3.25 (Filed With SEC on February 27, 2017)
- Alternate form of Warrant Exercise Agreement (Filed With SEC on February 24, 2017)
- Form of Warrant Exercise Agreement (Filed With SEC on February 24, 2017)
- Form of New Warrant (Filed With SEC on February 24, 2017)
- Alternate form of Securities Purchase Agreement (Filed With SEC on August 29, 2016)
- Form of Securities Purchase Agreement (Filed With SEC on August 29, 2016)